Susquehanna International Group, LLP Pds Biotechnology Corp Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 246,977 shares of PDSB stock, worth $330,949. This represents 0.0% of its overall portfolio holdings.

Number of Shares

246,977

Previous 134,260 83.95%

Holding current value

$330,949

Previous $512,000 21.48%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.63 - $4.11 $183,728 - $463,266	112,717 Added 83.95%	246,977 $402,000
Q3 2024 Nov 14, 2024	SELL	$2.93 - $4.23 $3,501 - $5,054	-1,195 Reduced 0.88%	134,260 $512,000
Q2 2024 Aug 15, 2024	SELL	$2.55 - $4.02 $136,963 - $215,918	-53,711 Reduced 28.39%	135,455 $396,000
Q1 2024 May 07, 2024	SELL	$3.85 - $6.59 $277,400 - $474,822	-72,052 Reduced 27.58%	189,166 $749,000
Q4 2023 Feb 14, 2024	BUY	$3.95 - $6.58 $318,689 - $530,880	80,681 Added 44.69%	261,218 $1.3 Million
Q3 2023 Nov 14, 2023	BUY	$4.8 - $6.4 $118,008 - $157,344	24,585 Added 15.76%	180,537 $911,000
Q2 2023 Aug 11, 2023	SELL	$5.03 - $9.9 $297,403 - $585,347	-59,126 Reduced 27.49%	155,952 $784,000
Q1 2023 May 16, 2023	BUY	$5.68 - $11.99 $550,477 - $1.16 Million	96,915 Added 82.02%	215,078 $1.32 Million
Q4 2022 Feb 14, 2023	BUY	$3.28 - $13.2 $193,749 - $779,724	59,070 Added 99.96%	118,163 $1.56 Million
Q3 2022 Nov 14, 2022	SELL	$2.97 - $5.79 $273,260 - $532,720	-92,007 Reduced 60.89%	59,093 $176,000
Q2 2022 Aug 15, 2022	BUY	$3.05 - $6.68 $43,645 - $95,590	14,310 Added 10.46%	151,100 $552,000
Q1 2022 May 16, 2022	SELL	$4.78 - $8.43 $767,237 - $1.35 Million	-160,510 Reduced 53.99%	136,790 $846,000
Q4 2021 Feb 14, 2022	SELL	$7.76 - $14.35 $295,485 - $546,419	-38,078 Reduced 11.35%	297,300 $2.41 Million
Q3 2021 Nov 15, 2021	BUY	$9.33 - $17.08 $1.94 Million - $3.55 Million	208,047 Added 163.39%	335,378 $5 Million
Q2 2021 Aug 11, 2021	BUY	$4.35 - $12.86 $553,889 - $1.64 Million	127,331 New	127,331 $1.6 Million

Others Institutions Holding PDSB

# of Institutions

Shares Held

4.22M

Call Options Held

170K

Put Options Held

6.7K

View Full List

About PDS Biotechnology Corp

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $38.1M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

More about PDSB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Pds Biotechnology Corp Transaction History